Company / Operating Cash Flow
Illumina, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$1.1B
FY2025
5-year range
$478.0M / $1.1B
FY2021-FY2025
Trend
+28.9%
vs FY2024
Sector context
#33 of 164
Health Care
What the data says
Illumina, Inc.'s operating cash flow of $1.1B is higher than 80% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 10 years, ranging from $478M in FY2023 to $1.1B in FY2022.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of -0.0%. Top quartile in the Health Care sector.
Improved from $478M to $1.1B over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Sector benchmark
+3.4% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.0%, indicating a declining trend.
- In FY2025, operating cash flow increased 28.9% year-over-year.
- Ranks #33 out of 164 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +28.9% |
| FY2024 | $837.0M | +75.1% |
| FY2023 | $478.0M | -55.7% |
| FY2022 | $1.1B | +98.2% |
| FY2021 | $545.0M | -49.5% |
| FY2020 | $1.1B | +23.4% |
| FY2019 | $875.0M | +12.3% |
| FY2018 | $779.0M | -0.9% |
| FY2017 | $786.0M | +0.9% |
| FY2016 | $779.0M | -0.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026